The second-quarter sales decline was mostly due to lower demand for the company’s COVID-19 vaccine.
Source link
Maryland Digital News > Blog > MARKET > Moderna’s stock slides 12% after it lowers full-year sales guidance
All posts byMarylandDigitalNews.com